← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2020-09-21

Drug application

FDA Application #

ANDA213465

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN

Generic name

SUMATRIPTAN

Active ingredients

SUMATRIPTAN

Dosage form

SPRAY

Route

NASAL

Marketing status

Prescription

Sponsor

PADAGIS ISRAEL

Manufacturer

Padagis Israel Pharmaceuticals Ltd

First approval

2020-09-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown